Molecules and methods of using same for treating CCR5/CCR5 ligands associated diseases

Details for Australian Patent Application No. 2007216170 (hide)

Owner Rappaport Family Institute for Research in the Medical Sciences

Inventors Wildbaum, Gizi; Karin, Nathan

Agent Cullen & Co

Pub. Number AU-A-2007216170

PCT Pub. Number WO2007/094005

Priority 60/774,191 17.02.06 US; 60/789,920 07.04.06 US

Filing date 18 February 2007

Wipo publication date 23 August 2007

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/094005 Priority application(s): WO2007/094005

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007216174-Process for producing a bio-pesticide composition containing Trichoderma harzianum and Pseudomonas fluorescens

2007216165-Applications of microencapsulated essential oils